|
Ki67 to predict RCB0/I after neoadjuvant chemotherapy and endocrine therapy in HER2- breast cancer patients from ABCSG 34. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Merck (Inst) |
|
|
Honoraria - Amgen; AstraZeneca; Celgene; Lilly; Roche |
Consulting or Advisory Role - Amgen; AstraZeneca; Novartis; Pfizer; Roche |
Research Funding - Roche (Inst) |
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche |
|
|
Honoraria - Amgen; AstraZeneca; Lilly; Novartis; Pfizer |
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; Pfizer |
Travel, Accommodations, Expenses - Amgen; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Celgene; Novartis; Pfizer; Roche |
Speakers' Bureau - Amgen; Celgene; Novartis; Pfizer; Pierre Fabre; Roche |
Research Funding - Amgen (Inst); Celgene (Inst) |
Travel, Accommodations, Expenses - Celgene; Pfizer; Roche |
|
|
Honoraria - Acraf; Amgen; MSD; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche |
Consulting or Advisory Role - Acraf; Amgen; MSD; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Acraf; Amgen; MSD; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche |
|
|
Honoraria - AstraZeneca; Roche |
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer |
Research Funding - AstraZeneca; Pfizer; Roche |
|
|
|
Research Funding - Amgen (Inst) |
Travel, Accommodations, Expenses - Amgen |
|
|
Consulting or Advisory Role - Lilly |
Research Funding - Roche (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Merck; Myriad Genetics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Novartis; Pfizer; Roche |
Consulting or Advisory Role - Novartis; Pfizer; Roche |
Research Funding - Novartis (Inst) |
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
Research Funding - Amgen (Inst) |
|
|
|
Honoraria - Amgen; AstraZeneca; Celgene; Lilly; NanoString Technologies; Novartis; Roche |
Consulting or Advisory Role - Accelsiors |
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Ipsen; Lilly; Medtronic; Novartis; Pfizer |